Ideal supplementary cementing material – Metakaolin: A review
International Review of Applied Sciences and Engineering · 2020-04 · 11 (1) · 58-65
DOI: 10.1556/1848.2020.00008 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Review of Applied Sciences and Engineering, 2020-04. Verfasst von G. Lizia Thankam und 1 weiteren Autor:innen. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Though being an ancient trend, usage of the homogeneous material cement in the construction industry is steadily getting eradicated with the springing up of supplementary cementing materials (SCM). Metakaolin is an imminent mineral admixture extracted from the mineral ore kaolinite, which enhances the interfacial zone by more efficient packing at the cement paste-aggregate particle interface, thus reducing the bleeding and producing a denser, more homogeneous transition zone microstructure. This paper depicts the various repercussions of the pozzolanic material metakaolin in the fresh and hardened properties of concrete when replaced with cement in finite amount. Also, it states the behavior of high-performance concrete and self-compacting concrete with metakaolin.
Zitieren
APA
Thankam, G. L., & Renganathan, N. T. (2020). Ideal supplementary cementing material – Metakaolin: A review. International Review of Applied Sciences and Engineering, 11(1), 58-65. https://doi.org/10.1556/1848.2020.00008
Vancouver
Thankam GL, Renganathan NT. Ideal supplementary cementing material – Metakaolin: A review. International Review of Applied Sciences and Engineering. 2020;11(1):58-65. doi:10.1556/1848.2020.00008
BibTeX
@article{Thankam2020,
author = {Thankam, G. Lizia and Renganathan, Neelakantan Thurvas},
title = {Ideal supplementary cementing material – Metakaolin: A review},
journal = {International Review of Applied Sciences and Engineering},
year = {2020},
volume = {11},
number = {1},
pages = {58--65},
doi = {10.1556/1848.2020.00008}
}
EUVIMED